Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 328

1.

Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.

Falsey AR, Becker KL, Swinburne AJ, Nylen ES, Snider RH, Formica MA, Hennessey PA, Criddle MM, Peterson DR, Walsh EE.

Int J Chron Obstruct Pulmon Dis. 2012;7:127-35. doi: 10.2147/COPD.S29149. Epub 2012 Feb 23.

2.

Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.

Tanrıverdi H, Örnek T, Erboy F, Altınsoy B, Uygur F, Atalay F, Tor MM.

Wien Klin Wochenschr. 2015 Oct;127(19-20):756-63. doi: 10.1007/s00508-014-0690-6. Epub 2015 Jan 14.

PMID:
25586444
3.

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.

Bafadhel M, Clark TW, Reid C, Medina MJ, Batham S, Barer MR, Nicholson KG, Brightling CE.

Chest. 2011 Jun;139(6):1410-8. doi: 10.1378/chest.10-1747. Epub 2010 Oct 28.

4.

Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study.

Daubin C, Parienti JJ, Fradin S, Vabret A, Ramakers M, Terzi N, Freymuth F, Charbonneau P, du Cheyron D.

BMC Infect Dis. 2009 Sep 21;9:157. doi: 10.1186/1471-2334-9-157.

5.

Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.

Lacoma A, Prat C, Andreo F, Lores L, Ruiz-Manzano J, Ausina V, Domínguez J.

Int J Chron Obstruct Pulmon Dis. 2011;6:157-69. doi: 10.2147/COPD.S16070. Epub 2011 Feb 28.

6.

Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.

Chang CH, Tsao KC, Hu HC, Huang CC, Kao KC, Chen NH, Yang CT, Tsai YH, Hsieh MJ.

Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:767-74. doi: 10.2147/COPD.S76740. eCollection 2015.

7.

Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.

Daubin C, Parienti JJ, Vabret A, Ramakers M, Fradin S, Terzi N, Freymuth F, Charbonneau P, du Cheyron D.

BMC Infect Dis. 2008 Oct 23;8:145. doi: 10.1186/1471-2334-8-145.

8.
9.

Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection.

Ingram PR, Inglis T, Moxon D, Speers D.

Intensive Care Med. 2010 Mar;36(3):528-32. doi: 10.1007/s00134-009-1746-3.

PMID:
20069274
10.

Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia.

Lubell Y, Blacksell SD, Dunachie S, Tanganuchitcharnchai A, Althaus T, Watthanaworawit W, Paris DH, Mayxay M, Peto TJ, Dondorp AM, White NJ, Day NP, Nosten F, Newton PN, Turner P.

BMC Infect Dis. 2015 Nov 11;15:511. doi: 10.1186/s12879-015-1272-6.

11.

Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease.

Elefsiniotis IS, Skounakis M, Vezali E, Pantazis KD, Petrocheilou A, Pirounaki M, Papatsibas G, Kontou-Kastellanou C, Moulakakis A.

Eur J Gastroenterol Hepatol. 2006 May;18(5):525-30.

PMID:
16607149
12.

Upper-respiratory viral infection, biomarkers, and COPD exacerbations.

Kherad O, Kaiser L, Bridevaux PO, Sarasin F, Thomas Y, Janssens JP, Rutschmann OT.

Chest. 2010 Oct;138(4):896-904. doi: 10.1378/chest.09-2225. Epub 2010 Apr 30.

PMID:
20435659
13.

C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.

Porfyridis I, Georgiadis G, Vogazianos P, Mitis G, Georgiou A.

Respir Care. 2014 Apr;59(4):574-81. doi: 10.4187/respcare.02741. Epub 2013 Oct 8.

14.

Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.

Jereb M, Kotar T.

Wien Klin Wochenschr. 2006 Apr;118(5-6):170-4.

PMID:
16773483
15.

Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.

Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guérin S, Ravilly S, Lefèvre H, Royer C, Lacombe C, Palmer P, Bohuon C.

Pediatr Infect Dis J. 1999 Oct;18(10):875-81.

PMID:
10530583
16.

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B.

Lancet. 2004 Feb 21;363(9409):600-7.

PMID:
14987884
17.

Procalcitonin is useful in identifying bacteraemia among children with pneumonia.

Nascimento-Carvalho CM, Cardoso MR, Barral A, Araújo-Neto CA, Guerin S, Saukkoriipi A, Paldanius M, Vainionpää R, Lebon P, Leinonen M, Ruuskanen O, Gendrel D.

Scand J Infect Dis. 2010 Sep;42(9):644-9. doi: 10.3109/00365541003796775.

PMID:
20438288
18.

Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations.

De Serres G, Lampron N, La Forge J, Rouleau I, Bourbeau J, Weiss K, Barret B, Boivin G.

J Clin Virol. 2009 Oct;46(2):129-33. doi: 10.1016/j.jcv.2009.07.010. Epub 2009 Aug 7.

PMID:
19665425
19.

Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines.

Reissig A, Mempel C, Schumacher U, Copetti R, Gross F, Aliberti S.

Lung. 2013 Jun;191(3):239-46. doi: 10.1007/s00408-013-9460-x. Epub 2013 Apr 6.

PMID:
23564195
20.

Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.

Polzin A, Pletz M, Erbes R, Raffenberg M, Mauch H, Wagner S, Arndt G, Lode H.

Eur Respir J. 2003 Jun;21(6):939-43.

Items per page

Supplemental Content

Write to the Help Desk